Second-line salvage chemotherapy for transplant-eligible patients with Hodgkin's lymphoma resistant to platinum-containing first-line salvage chemotherapy
about
GEM-P chemotherapy is active in the treatment of relapsed Hodgkin lymphoma.Salvage treatment for relapsed/refractory Hodgkin lymphoma: role of allografting, brentuximab vedotin and newer agents.Sequential immunotherapy in a patient with primary refractory Hodgkin lymphoma and novel mutations.Management of Lymphomas: Consensus Document 2018 by an Indian Expert Group
P2860
Second-line salvage chemotherapy for transplant-eligible patients with Hodgkin's lymphoma resistant to platinum-containing first-line salvage chemotherapy
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Second-line salvage chemothera ...... irst-line salvage chemotherapy
@ast
Second-line salvage chemothera ...... irst-line salvage chemotherapy
@en
type
label
Second-line salvage chemothera ...... irst-line salvage chemotherapy
@ast
Second-line salvage chemothera ...... irst-line salvage chemotherapy
@en
prefLabel
Second-line salvage chemothera ...... irst-line salvage chemotherapy
@ast
Second-line salvage chemothera ...... irst-line salvage chemotherapy
@en
P2093
P2860
P1433
P1476
Second-line salvage chemothera ...... irst-line salvage chemotherapy
@en
P2093
Christine Massey
Diego Villa
John Kuruvilla
Michael Crump
Noemi Puig
Tara Seshadri
P2860
P304
P356
10.3324/HAEMATOL.2011.047670
P577
2011-12-16T00:00:00Z